跳至主要内容
临床试验/IRCT2017063015446N11
IRCT2017063015446N11招募中未知

The effect of Tacrolimus on improving clinical symptoms, FEV1 and PEFR in patients with acute asthma attack ; Randomized clinical trial

Ahvaz Jundishapur University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • the age between 18 and 65 years; patients with shortness of breath; cases with a history of asthma that correlate with their clinical and paraclinical parameters
  • Exclusion criteria: The patients with tacrolimus allergy; HCO-60 (polyoxyl 60 hydrogenated castor oil); Hyperpigmentation scars, diabetes mellitus; renal failure; heart failure; electrolyte disorders; uncontrolled blood pressure; neurologic disorders; lymphoma and other malignancies; pregnancy and breast feeding

排除标准

  • 未提供

研究者

相似试验